Visit COVID-19 resources

[Skip to Content]

News

Redeployment considerations during the latest pandemic surge

Jan 07
2021

COVID-19 has led to a national lockdown in the New Year with increased infection rates putting immense pressure on frontline services which has meant the redeployment of ophthalmic staff, including ophthalmologists in training is already taking place. The Royal College of Ophthalmologists recognises that this is a necessary step to support the overall critical response

  • 7 January 2021

A message from the President at the start third national lockdown

Jan 06
2021

Dear colleagues As we enter into 2021, there is some light of optimism and hope at the end of what has been for many a long dark tunnel. Optimism that despite the serious challenges to maintaining eye care services that a third national lockdown presents, we have the guidance and knowledge, learnt in the first

  • 6 January 2021

Extra date for the OPT Training The Trainers programme

Dec 16
2020

The College is pleased to announce that an extra date has been added to the Spring 2021 OPT Training The Trainers programme and will be available to book shortly: OPT TTT – Friday 23 April 2021 (online, full day) Learning outcomes These courses are suitable for Ophthalmologists, Orthoptists, Optometrists and Ophthalmic Nurses who are experienced

  • 16 December 2020

The Eye To Eye Podcast Reaches Two Major Milestones

Dec 16
2020

This week the Eye to Eye Podcast has been listed as one of Eye News’ top five podcasts for trainees to listen to. In addition, the podcast has had it’s 10, 000th listen. Reaching these two major milestones in the same week is testament to the popularity of this broadcast. Top five podcast Eye News

  • 16 December 2020

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring

Dec 16
2020

Updated Guidelines December 2020 Following the publication of the RCOphth recommendations for monitoring in hydroxychloroquine and chloroquine users in 2018, new published evidence prompted a review of the guideline. Recent data have highlighted that hydroxychloroquine retinopathy is more common than previously reported. The prevalence in long-term users appears to be around 7.5% and depending on

  • 16 December 2020